Holders — by stockHoldings — by fund
Venrock Adviser, LLC
Everything this manager disclosed owning in US-listed stocks — its complete Form 13F portfolio · as of 2026-06-30 · filed with the SEC up to 45 days after quarter end · CIK 0001615982
$3.30B
disclosed book value
33
positions
34.2%
largest position share
Positions, as of 2026-06-30
top 33 of 33 · 13F covers long US-listed positions only — cash, bonds, private and foreign stakes are not disclosed · PUT/CALL tags = options positions (share-equivalents), not shares held
| # | Issuer | Shares | Value | % of book |
|---|---|---|---|---|
| 1 | APGEAPOGEE THERAPEUTICS INC | 8.5M | $1.13B | 34.2% |
| 2 | ORKAORUKA THERAPEUTICS INC | 4.1M | $394.8M | 12% |
| 3 | ERASERASCA INC | 17.9M | $327.8M | 9.9% |
| 4 | SYRESPYRE THERAPEUTICS INC | 3.0M | $265.0M | 8% |
| 5 | DNTHDIANTHUS THERAPEUTICS INC | 1.2M | $115.0M | 3.5% |
| 6 | OCULOCULAR THERAPEUTIX INC | 10.3M | $101.6M | 3.1% |
| 7 | DAMORA THERAPEUTICS INC | 3.6M | $93.7M | 2.8% |
| 8 | SVRASAVARA INC | 14.7M | $90.8M | 2.8% |
| 9 | JBIOJADE BIOSCIENCES INC | 3.2M | $71.6M | 2.2% |
| 10 | COGTCOGENT BIOSCIENCES INC | 1.6M | $63.6M | 1.9% |
| 11 | VRDNVIRIDIAN THERAPEUTICS INC | 3.3M | $59.8M | 1.8% |
| 12 | VORVOR BIOPHARMA INC | 3.0M | $56.0M | 1.7% |
| 13 | DYNDYNE THERAPEUTICS INC | 2.2M | $48.3M | 1.5% |
| 14 | MAZEMAZE THERAPEUTICS INC | 1.6M | $47.8M | 1.4% |
| 15 | RLMDRELMADA THERAPEUTICS INC | 6.8M | $47.4M | 1.4% |
| 16 | ORICORIC PHARMACEUTICALS INC | 4.3M | $46.8M | 1.4% |
| 17 | CRESCENT BIOPHARMA INC. | 2.1M | $38.4M | 1.2% |
| 18 | ZURA BIO LTD | 6.4M | $38.0M | 1.2% |
| 19 | ANLADLAI NORTYE LTD | 3.2M | $36.9M | 1.1% |
| 20 | ELVNENLIVEN THERAPEUTICS INC | 526,331 | $26.7M | 0.8% |
| 21 | HELPCYBIN INC | 3.9M | $25.5M | 0.8% |
| 22 | CGEMCULLINAN THERAPEUTICS INC | 1.4M | $25.1M | 0.8% |
| 23 | IPSCCENTURY THERAPEUTICS INC | 8.7M | $21.3M | 0.6% |
| 24 | ARTVARTIVA BIOTHERAPEUTICS INC | 2.0M | $19.8M | 0.6% |
| 25 | CTMXCYTOMX THERAPEUTICS INC | 5.0M | $18.7M | 0.6% |
| 26 | ACHVACHIEVE LIFE SCIENCE INC | 2.8M | $18.0M | 0.5% |
| 27 | PBLSPARABILIS MEDICINES INC | 625,000 | $17.1M | 0.5% |
| 28 | SRZNSURROZEN INC | 632,931 | $16.4M | 0.5% |
| 29 | KRROKORRO BIO INC | 1.0M | $13.3M | 0.4% |
| 30 | ANROALTO NEUROSCIENCE INC | 500,000 | $13.2M | 0.4% |
| 31 | XFORX4 PHARMACEUTICALS INC | 1.9M | $9.0M | 0.3% |
| 32 | RESEARCH ALLIANCE CORP III | 300,000 | $3.2M | 0.1% |
| 33 | INMINMED PHARMACEUTICALS INC | 32,685 | $50,662 | 0% |
Source: SEC Form 13F-HR, reporting period 2026-06-30. Values are the manager's filed June-30-style quarter-end marks, not live prices. Research, not investment advice.